Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Citalopram and psychological treatment for conversion disorder (motor type)
NL-OMON33963Phase 3Active, not recruiting
- Sponsor
- Pro Persona
- Start
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of citalopram in Dissociative neurological symptom disorder (DNSD) (3 arms), sponsored by Pro Persona. Primary endpoints: Improvement in intensity of conversion symptoms, Number of conversion symptoms and 1 more. Started Jan 2010; status: active, not recruiting.
02
Drugs
citalopram
03
Conditions
Dissociative neurological symptom disorder (DNSD)
Beyond the preview
Go deeper on NL-OMON33963.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON33963.